Drug
Abt 767
Abt 767: highest development phase Phase 1, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABT-767 NCT01339650 | Phase 1 | Fallopian Tube |
Latest
No recent events.
Follow Abt 767 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.